S

Sangamo Therapeutics

D
SGMO
USD
0.33
(13.3603%)
Market Closed
554,497.00
Volume
-0.435
EPS
-
Div Yield
-2.036232
P/E
583,017,876.00
Market Cap
Today
13.3603%
1 Week
63.743%
1 Month
250.000%
6 Months
418.711%
12 Months
569.056%
Year To Date
417.464%
All Time
0%

Title:
Sangamo Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
Do you need help or have a question?